(Q37084602)

18 August 2017

Economic evaluation of hepatitis B vaccination in low-income countries: using cost-effectiveness affordability curves (English)

1 reference

18 August 2017

1 reference

3

Sue J Goldie

1 reference

18 August 2017

2

Joshua A Salomon

1 reference

18 August 2017

Sun-Young Kim

1

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 November 2007

1 reference

18 August 2017

10

1 reference

Bulletin of the World Health Organization

inferred from page(s)

published in

1 reference

18 August 2017

85

1 reference

18 August 2017

11

1 reference

18 August 2017

833-842

1 reference

Limitations of acceptability curves for presenting uncertainty in cost-effectiveness analysis

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2636252

Chronic hepatitis B virus infection in the Asia-Pacific region and Africa: review of disease progression

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2636252

Decreasing incidence of hepatocellular carcinoma among children following universal hepatitis B immunization

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2636252

EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002 Geneva, Switzerland. Consensus statement (long version).

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2636252

29 September 2017

Hepatitis B in children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2636252

Model-based estimates of risks of disease transmission and economic costs of seven injection devices in sub-Saharan Africa.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2636252

Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2636252

Global control of hepatitis B virus infection.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2636252

Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2636252

Economic evaluation of vaccination programmes: a consensus statement focusing on viral hepatitis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2636252

Economic evaluations of hepatitis B immunization: a global review of recent studies (1994-2000).

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2636252

Economic evaluation of communicable disease interventions in developing countries: a critical review of the published literature.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2636252

Costs, effects and cost-effectiveness analysis of a mobile maternal health care service in West Kiang, The Gambia.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2636252

Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areas

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2636252

Cost-effectiveness of hepatitis B vaccine in The Gambia.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2636252

Cost-effectiveness of interferon-alpha 2b treatment for hepatitis B e antigen-positive chronic hepatitis B.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2636252

Setting priorities for the Children's Vaccine Initiative: a cost-effectiveness approach

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2636252

The transmission dynamics and control of hepatitis B virus in The Gambia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2636252

Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2636252

Impact of model, methodological, and parameter uncertainty in the economic analysis of vaccination programs

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2636252

A mathematical model to estimate global hepatitis B disease burden and vaccination impact.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2636252

New tendencies and strategies in international immunisation: GAVI and The Vaccine Fund.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2636252

Outcome of chronic hepatitis B in Caucasian children during a 20-year observation period.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2636252

18-year follow-up study of a prospective randomized trial of hepatitis B vaccinations without booster doses in children

3 September 2018

1 reference

12 December 2020

The influence of age on the development of the hepatitis B carrier state

1 reference

12 December 2020

Policy analysis of the use of hepatitis B, Haemophilus influenzae type b-, Streptococcus pneumoniae-conjugate and rotavirus vaccines in national immunization schedules

1 reference

12 December 2020

Affordability and cost-effectiveness: decision-making on the cost-effectiveness plane

1 reference

12 December 2020

Cost effectiveness of rotavirus vaccines and other interventions for diarrhoeal diseases: meeting report 2006

1 reference

12 December 2020

Opportunity costs and uncertainty in the economic evaluation of health care interventions

1 reference

12 December 2020

Identifiers

1 reference

18 August 2017

PubMed publication ID

18038073

1 reference